TickerFactsScreenerDevelopers

NEUROCRINE BIOSCIENCES INC (NBIX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $68.47M2009: $37.33M2010: $54.05M2011: $50.11M2012: $63.75M2013: $44.79M2014: $31.01M2015: $74.19M2016: $83.27M2017: $254.71M2018: $141.71M2019: $112.30M2020: $187.10M2021: $340.80M2022: $262.90M2023: $251.10M2024: $233.00M2025: $713.00M$713.00M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$713.00M+206.0%
2024$233.00M-7.2%
2023$251.10M-4.5%
2022$262.90M-22.9%
2021$340.80M+82.1%
2020$187.10M+66.6%
2019$112.30M-20.8%
2018$141.71M-44.4%
2017$254.71M+205.9%
2016$83.27M+12.2%
2015$74.19M+139.2%
2014$31.01M-30.8%
2013$44.79M-29.7%
2012$63.75M+27.2%
2011$50.11M-7.3%
2010$54.05M+44.8%
2009$37.33M-45.5%
2008$68.47M—